Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metronidazole in Perianal Crohn's Disease
NCT00509639Phase 3Completed
- Sponsor
- SLA Pharma
- Start
- May 2005
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Metronidazole 10% ointment with Placebo ointment (2 arms). Primary endpoint: Change in Perianal Crohn's Disease Activity Index at 4 weeks. Started May 2005; status: completed.
02
Drugs
metronidazole
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00509639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509639.